mycoplasma pneumoniae pneumonia
Conditions
Interventions
Docycline group:Doxycycline for injection
Azithromycin group:Azithromycin for injection
Sponsors
The First Hospital of Jilin University
Eligibility
Sex/Gender
All
Age
8 Years to 18 Years
Inclusion criteria
Inclusion criteria: (1) Age: Pediatric patients aged 8-18 years; (2) Meeting diagnostic criteria for Mycoplasma pneumoniae pneumonia; (3) Illness duration 38°C) and cough; (5) No prior treatment with azithromycin, doxycycline, or other anti-infective therapies for Mycoplasma pneumoniae, and no corticosteroid therapy before admission; (6) Patients and their guardians consent to participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients allergic to azithromycin or doxycycline; (2) Patients who have received azithromycin or doxycycline treatment within the recent two weeks; (3) Confirmed infection with other pathogens; (4) Unstable vital signs requiring interventions such as ventilatory support; (5) Coexisting severe underlying diseases (e.g., congenital heart disease, renal insufficiency, or immunodeficiency); (6) Children presenting with neutropenia (neutrophils 3 times the upper limit of normal).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory indicators;Adverse reactions;Lung imaging; | — |
Primary
| Measure | Time frame |
|---|---|
| Defervescence time; | — |
Countries
China
Contacts
Public ContactMan Gao
The First Hospital of Jilin University
Outcome results
None listed